725
Views
5
CrossRef citations to date
0
Altmetric
Commentary

TLR7 inhibition

A novel strategy for pancreatic cancer treatment?

&
Article: e23011 | Published online: 01 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Diana Shah, Andrea Comba, Syed M. Faisal, Padma Kadiyala, Gregory J. Baker, Mahmoud S. Alghamri, Robert Doherty, Daniel Zamler, Gabriel Nuñez, Maria G. Castro & Pedro R. Lowenstein. (2021) A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1. OncoImmunology 10:1.
Read now

Articles from other publishers (4)

Rasha M.A. Al-Humairi, Muna T. Al-Musawi & Ali H. Ad'hiah. (2019) Bidirectional expression of Toll-like receptor 7 gene in urinary bladder cancer and urinary tract infection of Iraqi patients. Gene Reports 17, pages 100491.
Crossref
Francesco Gentile, Marco Deriu, Khaled Barakat, Andrea Danani & Jack Tuszynski. (2018) A Novel Interaction Between the TLR7 and a Colchicine Derivative Revealed Through a Computational and Experimental Study. Pharmaceuticals 11:1, pages 22.
Crossref
Tanja Grimmig, Romana Moench, Jennifer Kreckel, Stephanie Haack, Felix Rueckert, Roberta Rehder, Sudipta Tripathi, Carmen Ribas, Anil Chandraker, Christoph Germer, Martin Gasser & Ana Waaga-Gasser. (2016) Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer. International Journal of Molecular Sciences 17:12, pages 2060.
Crossref
Shuanglin Deng, Shan Zhu, Yuan Qiao, Yong-Jun Liu, Wei Chen, Gang Zhao & Jingtao Chen. (2014) Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma. Protein & Cell 5:12, pages 899-911.
Crossref